Explore chapters and articles related to this topic
Postmenopause
Published in Carolyn Torkelson, Catherine Marienau, Beyond Menopause, 2023
Carolyn Torkelson, Catherine Marienau
And third, it is also important to understand that something that is “natural” can still have potential side effects, including interactions with medications or other supplements. If you experience any side effects, you should report them promptly to your practitioner.
Introduction
Published in Kirsti Kauppinen, Kristiina Alanko, Matti Hannuksela, Howard Maibach, Skin Reactions to Drugs, 2020
Side-effects of drugs cannot be avoided. Neither in vitro nor animal tests prior to the clinical use are usually useful in predicting probable hypersensitive reactions to drugs. In addition, clinical trials cannot identify those drugs that cause adverse reactions only in a small number of users or after prolonged and recurrent administration.1 Interactions of drugs ingested simultaneously may also be unexpected and an individual response to a drug is often unpredictable.
Understanding and using anti-depressant medication
Published in Chris Williams, Roch Cantwell, Karen Robertson, Overcoming Postnatal Depression, 2020
Chris Williams, Roch Cantwell, Karen Robertson
Many side effects disappear within a few days of starting the tablets as you get used to them. Sometimes anxiety can actually worsen how much we notice our symptoms. Your doctor should have gone through the possible side effects with you when you started treatment. But you can always ask them again if you are unsure. You can also read the patient information leaflet that comes with the tablets.
Factors associated with suboptimal retention in HIV pre-exposure prophylaxis care among men who have sex with men
Published in AIDS Care, 2023
Brooke G. Rogers, Collette Sosnowy, Philip A. Chan, Rupa R. Patel, Leandro A. Mena, Trisha Arnold, Courtney Gomillia, Alexandra Zanowick-Marr, Kate Curoe, Ashley Underwood, Jesus Villalobos, Christina Chu, Drew Galipeau, Madeline Montgomery, Amy S. Nunn
At the clinical level, patients expressed a desire for being able to access PrEP from multiple types of medical providers (including primary care) and in clinics physically near their homes or places of work but balanced that perspective with the need for LGBTQ+ culturally sensitive care, which they acknowledged, was often not available in smaller or rural health clinics. At the behavioral level, several men in our study chose to discontinue PrEP due to changes in their sexual behavior and HIV risk perception. Additionally, many participants shared they had discontinued PrEP because of concerns about significant side effects and/or long-term health risks. While it is true that some might have experienced side effects from new medication, in several cases, participants were attributing body symptoms to the medication. In these cases, having a patient navigator call or message patients about side effects and offer suggestions for coping with them may be a helpful strategy to improve engagement in care (Doblecki-Lewis et al., 2019; Pathela et al., 2020; Reback et al., 2019).
Paediatric adverse event rating scale: a measure of safety or efficacy? Novel analysis from the MADDY study
Published in Current Medical Research and Opinion, 2022
Brenda M. Y. Leung, Priya Srikanth, Barbara Gracious, Irene E. Hatsu, Gabriella Tost, Valerie Conrad, Jeanette M. Johnstone, L. Eugene Arnold
An additional measure was the Pediatric Adverse Event Rating Scale (PAERS), which was required by the United States (US) Food and Drug Administration (FDA) to provide systematic monitoring of possible adverse reactions to the intervention. An adverse event is any unintended negative event after a medication has been administered correctly, in contrast to a side effect, which is a foreseeable unwanted effect7. The PAERS was developed to systematically measure adverse events in pediatric clinical trials. It has been used to evaluate child-reported tolerability8, assess perceived tolerability from different perspectives (patient, parent, physician)9, and characterize psychotropic medication-related AEs in very young children10. Few studies have reported results of the PAERS as a key measure of interest.
Comparing Aerobic Exercise with Yoga in Anxiety Reduction: An Integrative Review
Published in Issues in Mental Health Nursing, 2022
Amanda K. Cole, Tamera Pearson, Mary Knowlton
Anxiety disorders are often underrecognized and undertreated by primary care physicians (Bandelow et al., 2017). First line pharmacological treatment for anxiety disorders are selective serotonin reuptake inhibitors (SSRIs) and selective serotonin norepinephrine reuptake inhibitors (SNRIs) (Bandelow et al., 2017). Common side effects from both classes of medication include nausea, restlessness, headache, fatigue, increased or decreased appetite, weight gain, tremor, sexual dysfunction (Bandelow et al., 2017). The onset of these side effects is most prevalent in the first two weeks of drug therapy and can lead to medication noncompliance or discontinuation of the medication altogether (Bandelow et al., 2017; Mason et al., 2019). There is also a risk of treatment failure with medications and often a requirement for more than one pharmacologic medication to manage anxiety. The first line nonpharmacologic treatment is cognitive behavioral therapy (CBT) in which a trained therapist helps correct distorted, maladaptive beliefs using thought exercises or real experiences to facilitate symptom reduction and improve functioning (Lebow, 2020). For CBT to work, the person needs to be highly motivated and willing to dedicate effort, both in and out of therapy sessions. Unfortunately, there is still an element of cultural disproval of psychotherapy that may hinder someone from seeking this type of treatment (Mason et al., 2019).